SelectScience
Join Free
NewsDrug Discovery & Development

Cytiva broadens Xcellerex X-platform to include 500 L and 2000 L bioreactors

Cytiva
28 Mar 2025

Product news

Cytiva Xcellerex X-platform portfolio

Cytiva Xcellerex X-platform portfolio

As researchers and scientists work to discover the next generation of advanced therapeutics, Cytiva is expanding the Xcellerex X-platform portfolio to meet their growing needs with the addition of 500 L and 2000 L bioreactors. The X-platform is a reliable and flexible single-use system designed to increase operational efficiencies and production capacity, while helping to lower costs, reduce risks, and bring life-changing therapeutics to the next clinical milestone faster.

Why the X-Platform is different

The X-platform bioreactor portfolio was designed to meet the process needs of early-stage clinical researchers all the way through to commercial manufacturing. Customers can easily scale from 50L to 2 000L and while also reducing the time spent optimizing. Additional features include:

  • An infrared-based camera that provides accurate detection of foam appearing in the process, allowing for early, automated intervention.
  • Working height management of exhaust filters and heaters designed to simplify filter changes and minimize the need for manipulations at height.
  • Quick and easy “off-the shelf” bag configuration and installation which helps reduce the risk of error. A rigid base construction ensures consistent installation of the single-use bioreactor bag, minimizing the risk of batch failure

Ludovic Brellier, President of Hardware Solutions, Cytiva, says, “Our customers need speed and flexibility to develop advanced therapeutics. The expansion of Cytiva’s Xcellerex X-platform portfolio and its additional features will help our customers scale their operations more efficiently. The design and functionality of the hardware, biocontainers and software will allow our customers to safely manufacture life changing therapeutics faster.”

Showcasing at InterPhex 2025

The 2 000L X-platform bioreactor will be on display at Cytiva's Booth (#2815) at InterPhex, in New York City, from April 1-3, 2025.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Related products

Request Quote for All Products

Xcellerex™ X-platform bioreactors

Cytiva

Designed to address your cell culture needs, Xcellerex™ X-platform bioreactors combine high performance and flexibility with the reliability of Xcellerex™ single-use technologies.

(0)

Links

CytivaCompany website

Tags

Cell / Tissue CultureCell culture or tissue culture is used to study the biology of cells or tissues and to isolate cellular products in an environment which can be manipulated and well defined. Accurately control your culture environment with bioreactors or culture incubators, bind your cells to a surface or together with an extracellular matrix. Distinguish cell types with differential media or proliferate cells with certain characteristics using selective media. Enrich your media with supplements such as growth factors, sera and vitamins. Find the best cell and tissue culture products, kits and equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Bioprocessing / FermentationBioprocessing is the use of biological materials to perform commercial, scientific or medical research processes. Biological materials used include cells, enzymes and organisms. Usually bioprocessing requires a batch or continuous bioreactor such as a fermentor or cell culture system. The advantages of using a reactor include high productivity, easy configuration, adjustable values and automation.BioprocessingBioprocessing is the use of biological systems for the conversion of raw materials to desired products. This includes the research, development and manufacturing stages of production and can refer to food processing, small-molecule pharmaceutical manufacture, production of recombinant protein therapeutics, or the generation of renewable energy.Clinical TrialsTherapeutic AntibodiesTherapeutic antibodies are antibodies engineered for use in treating diseases. They can be designed to target specific antigens, blocking harmful interactions or modulating immune responses. Therapeutic antibodies are critical in treating conditions like cancer, autoimmune disorders, and infectious diseases. Explore the best therapeutic antibody products in our peer-reviewed product directory; compare options, check reviews, and get pricing directly from manufacturers.BiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.BiotherapeuticsBiotherapeutics are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or in <i>in vivo</i> diagnostics. The most well-known example of a biotherapeutic product, and the first to be approved for therapeutic use, was recombinant human insulin.Cell TherapyCell therapy involves using living cells to treat diseases, often by replacing damaged cells or stimulating regeneration. Stem cell therapy and CAR-T cell therapy are examples of cutting-edge treatments in regenerative medicine and cancer immunotherapy. Browse our peer-reviewed product directory to find the best cell therapy tools, compare products, check reviews, and get pricing directly from manufacturers.

Related articles